U.S. flag

An official website of the United States government

  • delete

NM_001130978.1(DYSF):c.200_201delTGinsAT (p.Val67Asp) AND Miyoshi myopathy

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 26, 2000
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000170323.4

Allele description

NM_001130978.1(DYSF):c.200_201delTGinsAT (p.Val67Asp)

Gene:
DYSF:dysferlin [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
2p13.2
Genomic location:
Preferred name:
NM_001130978.1(DYSF):c.200_201delTGinsAT (p.Val67Asp)
HGVS:
  • NC_000002.12:g.71481934_71481935delTGinsAT
  • NG_008694.1:g.33312_33313delTGinsAT
  • NM_001130978.1:c.200_201delTGinsAT
  • NM_001130987.1:c.203_204delTGinsAT
  • NM_003494.3:c.200_201delTGinsAT
  • NP_001124450.1:p.Val67Asp
  • NP_001124459.1:p.Val68Asp
  • NP_003485.1:p.Val67Asp
  • NC_000002.11:g.71709064_71709065delTGinsAT
Protein change:
V67D; VAL67ASP
Links:
OMIM: 603009.0009; dbSNP: rs121908957
NCBI 1000 Genomes Browser:
rs121908957
Molecular consequence:
  • NM_003494.3:c.200_201delTGinsAT - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Miyoshi myopathy
Synonyms:
Miyoshi muscular dystrophy
Identifiers:
MedGen: CN230453; OMIM: PS254130

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000222734OMIM
no assertion criteria provided
Pathogenic
(Dec 26, 2000)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy.

Illarioshkin SN, Ivanova-Smolenskaya IA, Tanaka H, Vereshchagin NV, Markova ED, Poleshchuk VV, Lozhnikova SM, Sukhorukov VS, Limborska SA, Slominsky PA, Bulayeva KB, Tsuji S.

Brain. 1996 Dec;119 ( Pt 6):1895-909.

PubMed [citation]
PMID:
9009996

Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.

Illarioshkin SN, Ivanova-Smolenskaya IA, Greenberg CR, Nylen E, Sukhorukov VS, Poleshchuk VV, Markova ED, Wrogemann K.

Neurology. 2000 Dec 26;55(12):1931-3.

PubMed [citation]
PMID:
11134403

Details of each submission

From OMIM, SCV000222734.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a large consanguineous Russian family with both limb-girdle muscular dystrophy type 2B (LGMD2B; 253601) and Miyoshi myopathy (MMD1; 254130) reported by Illarioshkin et al. (1996), Illarioshkin et al. (2000) found that all affected individuals were homozygous for a TG-to-AT change at nucleotides 573-574 of the DYSF gene, resulting in a val67-to-asp (V67D) substitution.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 21, 2018